Great West Life Assurance CO Geron Corp Transaction History

Great West Life Assurance CO

$53.1 Billion
Q2 2024

A detailed history of Great West Life Assurance CO transactions in Geron Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 147,280 shares of GERN stock, worth $664,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,280

Previous 64,438 128.56%

Holding current value

$664,232

Previous $212,000 194.34%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$3.1 - $5.09 $256,810 - $421,665	82,842 Added 128.56%	147,280 $624,000
Q1 2024 May 13, 2024	BUY	$1.75 - $3.44 $12,309 - $24,196	7,034 Added 12.25%	64,438 $212,000
Q4 2023 Feb 13, 2024	SELL	$1.74 - $2.31 $6,994 - $9,286	-4,020 Reduced 6.54%	57,404 $120,000
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $58,658 - $91,184	27,800 Added 82.68%	61,424 $130,000
Q2 2023 Aug 10, 2023	SELL	$1.97 - $3.69 $2,738 - $5,129	-1,390 Reduced 3.97%	33,624 $109,000
Q1 2023 May 12, 2023	BUY	$2.14 - $3.4 $14,885 - $23,650	6,956 Added 24.79%	35,014 $76,000
Q4 2022 Feb 10, 2023	SELL	$2.03 - $2.42 $2,131 - $2,541	-1,050 Reduced 3.61%	28,058 $68,000
Q3 2022 Nov 01, 2022	BUY	$1.67 - $2.94 $19,492 - $34,315	11,672 Added 66.94%	29,108 $68,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $1.65 $20,748 - $28,769	17,436 New	17,436 $27,000
Q2 2022 Aug 09, 2022	SELL	$1.19 - $1.65 $20,310 - $28,162	-17,068 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.99 - $1.6 $4,001 - $6,467	4,042 Added 31.03%	17,068 $24,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $4,677 - $6,594	3,834 Added 41.71%	13,026 $16,000
Q2 2021 Aug 11, 2021	SELL	$1.25 - $1.83 $21,665 - $31,717	-17,332 Reduced 65.34%	9,192 $13,000
Q3 2020 Nov 17, 2020	BUY	$1.59 - $2.19 $42,173 - $58,087	26,524 New	26,524 $46,000
Q3 2020 Nov 13, 2020	SELL	$1.59 - $2.19 $42,173 - $58,087	-26,524 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.05 - $2.18 $20,552 - $42,671	19,574 Added 281.64%	26,524 $57,000
Q4 2019 Feb 11, 2020	BUY	$1.27 - $1.54 $8,826 - $10,703	6,950 New	6,950 $9,000
Q3 2019 Oct 25, 2019	SELL	$1.15 - $1.59 $15,062 - $20,825	-13,098 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$1.99 - $2.65 $26,065 - $34,709	13,098	13,098 $29,000

Others Institutions Holding GERN

# of Institutions

257

Shares Held

448M

Call Options Held

1.91M

Put Options Held

897K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.7B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Geron Corp Transaction History